Ren Chong, McGrath Colman, Yang Yanqi
Faculty of Dentistry, The University of Hong Kong, 34 Hospital Road, Sai Ying Pun, Hong Kong SAR, China.
Lasers Med Sci. 2015 Sep;30(7):1881-93. doi: 10.1007/s10103-015-1743-4. Epub 2015 Mar 24.
To assess the effectiveness of diode low-level laser therapy (LLLT) for orthodontic pain control, a systematic and extensive electronic search for randomised controlled trials (RCTs) investigating the effects of diode LLLT on orthodontic pain prior to November 2014 was performed using the Cochrane Library (Issue 9, 2014), PubMed (1997), EMBASE (1947) and Web of Science (1956). The Cochrane tool for risk of bias evaluation was used to assess the bias risk in the chosen data. A meta-analysis was conducted using RevMan 5.3. Of the 186 results, 14 RCTs, with a total of 659 participants from 11 countries, were included. Except for three studies assessed as having a 'moderate risk of bias', the RCTs were rated as having a 'high risk of bias'. The methodological weaknesses were mainly due to 'blinding' and 'allocation concealment'. The meta-analysis showed that diode LLLT significantly reduced orthodontic pain by 39 % in comparison with placebo groups (P = 0.02). Diode LLLT was shown to significantly reduce the maximum pain intensity among parallel-design studies (P = 0.003 versus placebo groups; P = 0.000 versus control groups). However, no significant effects were shown for split-mouth-design studies (P = 0.38 versus placebo groups). It was concluded that the use of diode LLLT for orthodontic pain appears promising. However, due to methodological weaknesses, there was insufficient evidence to support or refute LLLT's effectiveness. RCTs with better designs and appropriate sample power are required to provide stronger evidence for diode LLLT's clinical applications.
为评估二极管低强度激光疗法(LLLT)对正畸疼痛控制的有效性,我们利用考克兰图书馆(2014年第9期)、PubMed(1997年起)、EMBASE(1947年起)和科学网(1956年起),对2014年11月之前调查二极管LLLT对正畸疼痛影响的随机对照试验(RCT)进行了系统且广泛的电子检索。采用考克兰偏倚风险评估工具来评估所选数据中的偏倚风险。使用RevMan 5.3进行荟萃分析。在186项结果中,纳入了14项RCT,共有来自11个国家的659名参与者。除三项研究被评估为具有“中度偏倚风险”外,这些RCT被评定为具有“高度偏倚风险”。方法学上的弱点主要归因于“盲法”和“分配隐藏”。荟萃分析表明,与安慰剂组相比,二极管LLLT可使正畸疼痛显著降低39%(P = 0.02)。在平行设计研究中,二极管LLLT被证明可显著降低最大疼痛强度(与安慰剂组相比,P = 0.003;与对照组相比,P = 0.000)。然而,在口内对照设计研究中未显示出显著效果(与安慰剂组相比,P = 0.38)。得出的结论是,使用二极管LLLT治疗正畸疼痛似乎很有前景。然而,由于方法学上的弱点,没有足够的证据支持或反驳LLLT的有效性。需要设计更好且样本量合适的RCT,为二极管LLLT的临床应用提供更有力的证据。